awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38012156-05B8A99D-DD4A-4CA0-A57B-BF5CEC149ABC
Q38012156-05B8A99D-DD4A-4CA0-A57B-BF5CEC149ABC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38012156-05B8A99D-DD4A-4CA0-A57B-BF5CEC149ABC
Sorafenib in locally advanced or metastatic breast cancer.
P2860
Q38012156-05B8A99D-DD4A-4CA0-A57B-BF5CEC149ABC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38012156-05B8A99D-DD4A-4CA0-A57B-BF5CEC149ABC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2b297d69d9763c5a34f938768b5c44a3bec989f1
P2860
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.